Clinical Trial Update: Aldesleukin With or Without Vaccine Therapy in Treating Patients With Stage IV Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Aldesleukin with or without vaccine therapy in Stage IV melanoma has completed and results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Aldesleukin (interleukin-2)

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Stage IV Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2012-12-13